Less than 20 people with MAAID have been reported, with clinical follow-up only available for 9 of them; among these, bi-allelic variants in the GSTZ1 gene were identified in only eight individuals [6,7]. Here, GSTZ1 is linked to maleylacetoacetate isomerase deficiency.